Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Postoperative recurrence rates with ustekinumab and vedolizumab. Unless otherwise stated, recurrence rates were assessed between 6 and 12 months postoperatively.
| Endoscopic Recurrence (%) | ||
|---|---|---|
| Study | Vedolizumab | Ustekinumab |
| Yamada et al. [61] | 17/22 (75) | NA |
| Buisson et al. [62] | NA | 9/32 (28) |
| Axelrad et al. [63] 1 | 13/27 (48) | 10/28 (36) |
| Yanai et al. [64] | 13/39 (33) | 21/34 (62) |
1 Median follow-up of 29 months. Figures combine endoscopic and radiographic recurrence.
